Recommandation pour la prise en charge d'une RTU
Traitement de la maladie de Takayasu répondant aux critères d’Ishikawa et résistant aux traitements conventionnels (corticoïdes et immunosuppresseurs
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
g5BA9M0f1z3jUe72
Listen
